Dr. Beth Jonas answers the question: 'Newer Vs. Older DMARDs for Rheumatoid?' — -- Question: How do the older DMARDs differ from the newer DMARDs and is either group of drugs better for the ...

Psoriatic arthritis (PsA) is a long-term, inflammatory disease affecting the joints and where tendons and ligaments connect to the bones. It doesn't have a cure. But a growing number of treatments can ...

DMARDs, including TNF-alpha inhibitors, may relieve pain and inflammation and help prevent joint damage from rheumatoid arthritis (RA). TNF-alpha inhibitors block TNF-alpha, which causes joint pain ...

Most people start a disease modifying antirheumatic drug (DMARD), such as methotrexate, soon after RA diagnosis. If you're still adjusting to a DMARD or want to better understand how it slows joint ...

ATLANTA — Biologic DMARDs were as efficacious among patients with rheumatoid arthritis aged 60 years and older at disease onset as it was among younger patients, with comparable rates of drug ...

A study looked at more than 23,600 Medicare beneficiaries with RA who had received a ≥30-day prescription of an opioid drug. Participants were grouped according to those who had been prescribed a ...

DMARDs are a medication that suppresses the immune system. People may take them to slow disease progression in autoimmune or inflammatory conditions, such as different types of arthritis. Inflammation ...

Please provide your email address to receive an email when new articles are posted on . Biologic disease-modifying antirheumatic drugs used to treat juvenile rheumatic diseases are excluded entirely ...

A study conducted at Copenhagen University Hospital showed that treatment of rheumatoid arthritis (RA) with disease modifying antirheumatic drugs (DMARDs), glucocorticoids, biologic agents, or a ...

February 13, 2012 — The vast majority of clinical trials of disease-modifying antirheumatic drugs (DMARDs) do not meet basic standards of comparative effectiveness research, a new study shows.

ROCKVILLE, Md., Sept. 26, 2011 /PRNewswire-USNewswire/ -- Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with ...

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints such ...